home / stock / abscf / abscf message board
Subject | By | Source | When |
---|---|---|---|
Stock Tracker: Latest Ab Science Paris (ABSCF) Headlines AB Science: initiation of a new phase 3 stu | Stock_Tracker | investorshangout | 03/08/2014 9:34:50 PM |
chartguy89: ABSCF 19.62 Stock Charts $ABSCF 1 Month Chart | chartguy89 | investorshangout | 03/05/2014 10:56:04 PM |
Stock Tracker: ABSCF Recent News AB Science: initiation of a new phase 3 study with masitinib in Pro | Stock_Tracker | investorshangout | 03/02/2014 4:23:40 AM |
chartguy89: ABSCF Stock Charts Saturday, February 22, 2014 at 12:18:40 AM $ABSCF Last: +0.92 | chartguy89 | investorshangout | 02/22/2014 5:18:51 AM |
chartguy89: ABSCF Stock Chart 19.62 Saturday, February 8, 2014 00:19:39 AM | chartguy89 | investorshangout | 02/08/2014 5:19:45 AM |
News, Short Squeeze, Breakout and More Instantly...
Ab Science Paris Ord Company Name:
ABSCF Stock Symbol:
OTCMKTS Market:
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development Continuation of the conditional marketing authorisation application procedures with the European Medicines Agency (EMA) and Health Cana...
PRESS RELEASE AB SCIENCE ANNOUNCES ISSUANCE OF A EUROPEAN PATENT FOR MASITINIB IN THE TREATMENT OF SEVERE MASTOCYTOSIS WITH PROTECTION UNTIL 2036 Paris, May 13, 2024, 6pm CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the European patent office has...
PRESS RELEASE A NEW PUBLICATION IN THE MEDICAL JOURNAL MUSCLE & NERVE VALIDATES THE USE OF THE RATE OF DECLINE OF ALSFRS-R SCORE (ΔFS) FOR THE DESIGN OF CLINICAL STUDIES AND THE TREATMENT CHOICE FOR AMYOTROPHIC LATERAL SCLEROSIS (ALS) PATIENTS THIS PUBLICATI...